Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn? (Q30981933)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn?	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

review article

1 reference

stated in

Europe PubMed Central

title

Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

author name string

M R Dewji

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

publication date

1 November 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

published in

Journal of Chemotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

volume

16 Suppl 4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

page(s)

44-48

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

cites work

The Hallmarks of Cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.44

retrieved

21 January 2018

Cell signaling by receptor tyrosine kinases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.44

retrieved

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.44

retrieved

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.44

retrieved

21 January 2018

The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.44

retrieved

21 January 2018

Untangling the ErbB signalling network

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.44

retrieved

21 January 2018

Identifiers

DOI

10.1179/JOC.2004.16.SUPPLEMENT-1.44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

PubMed publication ID

15688609

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15688609

retrieved

28 June 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30981933&oldid=2220449628"